This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

8 Jan 2013

Clinigen Group manages EU patient program

Clinigen Group is managing a patient program for a drug used to treat overexposure to chemotherapy.


Clinigen Global Access Program (GAP) will be managing a patient program in 37 European Union member states to test a potential antidote for overexposure to chemotherapy.

Related News